CYRX
Cryoport, Inc.
NasdaqCMUSDEQUITY
Industrials
DELAYED
Strong buy
+71/100
Last price
17.80
▼ 0.34 (1.87%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
18.34
Prev close
18.14
Day high
18.36
Day low
17.45
Volume
1.17M
Market cap
$901.55M
P/E (TTM)
—
52W range
7.61 – 18.36
Day trading desk
Gap from prior close
+1.08%
Prior close 18.14
VWAP
17.77
+0.16% from price
Relative volume
2.37×
Unusually busy
Session range
5.53%
17.44 – 18.41
Position in range
37%
Mid range
ATR (14D)
0.60
3.35% of price
Prior day high
18.24
PDH
Prior day low
17.30
PDL
Bid / ask spread
—
Quote not published
Session volume
1.47M
Avg 619.50K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+2.77%
+0.8%
1M
+12.59%
+11.4%
3M
+16.64%
+12.1%
6M
+93.27%
+75.1%
YTD
+85.42%
+71.2%
1Y
+83.88%
+67.5%
3Y
+29.83%
-52.4%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on CYRX open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
-26.03K
Net selling
Buy transactions
7
230.41K shares
Sell transactions
4
256.44K shares
Net transactions
+11
Buys less sells
Sell : buy shares
1.1 : 1
Mixed
Insider-held shares
1.95M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 11, 26 | SHELTON JERRELL WILSON Chief Executive Officer |
SELL | 28.80K | $429.38K | Direct |
| Jun 11, 26 | ZECCHINI EDWARD J Officer |
CONVERSION | 35.00K | $168.00K | Direct |
| Jun 11, 26 | ZECCHINI EDWARD J Officer |
SELL | 35.00K | $507.56K | Direct |
| Jun 8, 26 | MANDALAM RAMKUMAR Director |
SELL | 23.21K | $358.45K | Direct |
| Jun 5, 26 | BADDOUR LINDA Director |
STOCK | 10.35K | $0 | Direct |
| Jun 5, 26 | HARIRI ROBERT J Director |
STOCK | 10.35K | $0 | Direct |
| Jun 5, 26 | MANDALAM RAMKUMAR Director |
STOCK | 10.35K | $0 | Direct |
| Jun 5, 26 | HANCOCK DANIEL M Director |
STOCK | 10.35K | $0 | Direct |
| Jun 4, 26 | STEFANOVICH ROBERT STEVEN Chief Financial Officer |
SELL | 169.43K | $2.76M | Direct |
| Apr 21, 26 | SHELTON JERRELL WILSON Chief Executive Officer |
CONVERSION | 104.01K | $194.49K | Direct |
| Apr 6, 26 | SHELTON JERRELL WILSON Chief Executive Officer |
CONVERSION | 50.00K | $93.50K | Direct |
| Mar 23, 26 | SHELTON JERRELL WILSON Chief Executive Officer |
CONVERSION | 25.00K | $46.75K | Direct |
| Mar 23, 26 | SAWICKI MARK W Officer |
SELL | 1.34K | $10.97K | Direct |
| Mar 23, 26 | STEFANOVICH ROBERT STEVEN Chief Financial Officer |
SELL | 1.09K | $8.95K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BADDOUR LINDA |
Director | 68.10K | Stock Award(Grant) |
HANCOCK DANIEL M |
Director | 69.05K | Stock Award(Grant) |
HARIRI ROBERT J |
Director | 61.63K | Stock Award(Grant) |
MANDALAM RAMKUMAR |
Director | 67.89K | Sale |
SAWICKI MARK W |
Officer | 102.36K | Sale |
SHELTON JERRELL WILSON |
Chief Executive Officer | 1.20M | Sale |
STEFANOVICH ROBERT STEVEN |
Chief Financial Officer | 109.85K | Sale |
ZECCHINI EDWARD J |
Officer | 109.72K | Conversion of Exercise of derivative security |
Fundamentals
Market cap$901.55M
Enterprise value$783.15M
Revenue (TTM)$186.45M
Gross profit$87.77M
EBITDA$-3.46M
Net income$-40.90M
EPS (TTM)$-0.81
Free cash flow$-14.68M
Total cash$396.69M
Total debt$232.02M
Book value / share$8.78
Shares outstanding50.65M
Float45.95M
Short % of float6.62%
Dividend yield0.00%
Beta (5Y)1.96
Valuation & profitability ratios
Trailing P/E—
Forward P/E-26.83
PEG ratio62.13
Price / sales—
Price / book2.03
EV / revenue4.20
EV / EBITDA-226.54
Gross margin47.08%
Operating margin-20.45%
Profit margin-20.05%
Return on equity-6.54%
Return on assets-2.39%
Debt / equity47.28
Current ratio2.08
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $176.18M | $156.77M | $168.66M | $237.28M | +12.4% |
| Operating revenue | $176.18M | $156.77M | $168.66M | $237.28M | +12.4% |
| Cost of revenue | $93.12M | $87.11M | $93.33M | $133.40M | +6.9% |
| Gross profit | $83.05M | $69.66M | $75.33M | $103.87M | +19.2% |
| Research & development | $17.04M | $17.71M | $18.04M | $15.72M | -3.8% |
| Selling, general & admin | $102.82M | $109.81M | $108.26M | $120.06M | -6.4% |
| Total operating expense | $119.86M | $127.52M | $126.30M | $135.78M | -6.0% |
| Operating income | -$36.81M | -$57.86M | -$50.97M | -$31.90M | +36.4% |
| Net interest income | -$2.36M | -$3.98M | -$5.58M | -$6.14M | +40.6% |
| Pre-tax income | -$32.17M | -$104.35M | -$84.21M | -$35.09M | +69.2% |
| Tax provision | $1.80M | $359.00K | $345.00K | $2.24M | +401.1% |
| Net income | $78.30M | -$114.76M | -$99.59M | -$37.33M | +168.2% |
| Net income to common | $70.30M | -$122.76M | -$107.59M | -$45.33M | +157.3% |
| Basic EPS | 1.40 | -2.49 | -2.21 | -0.93 | +156.2% |
| Diluted EPS | 1.40 | -2.49 | -2.21 | -0.93 | +156.2% |
| EBIT | -$29.81M | -$100.37M | -$78.63M | -$28.95M | +70.3% |
| EBITDA | -$2.10M | -$69.61M | -$51.15M | -$6.19M | +97.0% |
| Basic shares | 50.07M | 49.35M | 48.74M | 48.99M | +1.5% |
| Diluted shares | 50.07M | 49.35M | 48.74M | 48.99M | +1.5% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $250.49M | $34.14M | $46.35M | $36.59M | +633.8% |
| Cash & short-term investments | $411.21M | $250.60M | $456.75M | $523.32M | +64.1% |
| Accounts receivable | $33.36M | $25.30M | $42.07M | $43.86M | +31.8% |
| Inventory | $23.19M | $21.48M | $26.21M | $27.68M | +8.0% |
| Total current assets | $476.17M | $341.57M | $535.11M | $604.18M | +39.4% |
| Property, plant & equipment | $125.17M | $119.93M | $117.51M | $90.48M | +4.4% |
| Goodwill & intangibles | $160.48M | $168.50M | $302.79M | $342.13M | -4.8% |
| Total assets | $764.99M | $703.49M | $957.74M | $1.04B | +8.7% |
| Total current liabilities | $219.02M | $64.56M | $45.61M | $40.85M | +239.2% |
| Current debt | $185.26M | $14.44M | $149.00K | $60.00K | +1,182.9% |
| Long-term debt | $1.09M | $185.03M | $379.89M | $407.06M | -99.4% |
| Total debt | $230.72M | $242.54M | $416.00M | $435.91M | -4.9% |
| Total liabilities | $262.35M | $301.59M | $468.72M | $482.91M | -13.0% |
| Retained earnings | -$688.88M | -$757.17M | -$642.42M | -$542.83M | +9.0% |
| Shareholder equity | $502.64M | $401.90M | $489.02M | $555.84M | +25.1% |
| Working capital | $257.16M | $277.01M | $489.50M | $563.33M | -7.2% |
| Net tangible assets | $342.16M | $233.40M | $186.24M | $213.71M | +46.6% |
| Shares issued | 49.85M | 49.91M | 48.97M | 48.33M | -0.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $78.30M | -$114.76M | -$99.59M | -$37.33M | +168.2% |
| Depreciation & amortisation | $27.71M | $30.76M | $27.49M | $22.77M | -9.9% |
| Stock-based compensation | $11.03M | $19.70M | $22.81M | $20.08M | -44.0% |
| Change in working capital | -$13.69M | -$8.61M | -$1.20M | -$32.07M | -59.1% |
| Operating cash flow | -$8.58M | -$16.32M | -$757.00K | -$1.85M | +47.4% |
| Capital expenditure | -$19.50M | -$21.27M | -$44.90M | -$24.20M | +8.3% |
| Investing cash flow | $250.32M | $176.81M | $36.05M | -$59.68M | +41.6% |
| Share buybacks | -$10.01M | $0 | $0 | -$37.96M | — |
| Financing cash flow | -$21.07M | -$161.53M | -$23.80M | -$39.17M | +87.0% |
| Free cash flow | -$28.09M | -$37.59M | -$45.66M | -$26.05M | +25.3% |
| End cash position | $250.49M | $45.29M | $46.35M | $36.59M | +453.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $48.97M | $47.80M | $45.45M | $44.23M | $45.45M | +2.5% |
| Operating revenue | $48.97M | $47.80M | $45.45M | $44.23M | $45.45M | +2.5% |
| Cost of revenue | $26.15M | $25.89M | $23.74M | $22.91M | $24.08M | +1.0% |
| Gross profit | $22.82M | $21.91M | $21.71M | $21.32M | $21.38M | +4.2% |
| Research & development | $4.85M | $3.91M | $4.47M | $4.52M | $4.12M | +24.2% |
| Selling, general & admin | $28.01M | $27.62M | $27.28M | $26.73M | $26.91M | +1.4% |
| Total operating expense | $32.86M | $31.53M | $31.74M | $31.26M | $31.03M | +4.2% |
| Operating income | -$10.04M | -$9.61M | -$10.03M | -$9.93M | -$9.65M | -4.4% |
| Net interest income | -$518.00K | -$432.00K | -$634.00K | -$526.00K | -$618.00K | -19.9% |
| Pre-tax income | -$7.75M | -$9.32M | -$7.39M | -$6.53M | -$11.74M | +16.9% |
| Tax provision | $505.00K | $108.00K | $1.13M | $165.00K | $274.00K | +367.6% |
| Net income | -$8.26M | -$10.54M | -$11.64M | -$6.94M | $108.87M | +21.7% |
| Net income to common | -$10.26M | -$12.54M | -$13.64M | -$8.94M | $106.87M | +18.2% |
| Basic EPS | -0.20 | -0.25 | -0.27 | -0.18 | 2.05 | +20.0% |
| Diluted EPS | -0.20 | -0.25 | -0.27 | -0.18 | 2.05 | +20.0% |
| EBIT | -$7.23M | -$8.89M | -$6.76M | -$6.00M | -$11.12M | +18.7% |
| EBITDA | -$643.00K | -$2.49M | -$406.00K | $410.00K | -$3.83M | +74.2% |
| Basic shares | 50.44M | 49.90M | 49.76M | 50.13M | 50.26M | +1.1% |
| Diluted shares | 50.44M | 49.90M | 49.76M | 50.13M | 50.26M | +1.1% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $269.27M | $272.91M | $250.49M | $255.81M | $243.42M | — | -1.3% |
| Cash & short-term investments | $396.69M | $403.63M | $411.21M | $421.31M | $425.98M | — | -1.7% |
| Accounts receivable | $36.45M | $39.00M | $33.36M | $34.91M | $33.41M | — | -6.5% |
| Inventory | $21.51M | $21.75M | $23.19M | $23.33M | $23.04M | — | -1.1% |
| Total current assets | $460.20M | $470.54M | $476.17M | $484.84M | $489.49M | — | -2.2% |
| Property, plant & equipment | $134.84M | $129.10M | $125.17M | $123.46M | $119.77M | — | +4.4% |
| Goodwill & intangibles | $158.06M | $160.86M | $160.48M | $163.66M | $162.30M | — | -1.7% |
| Total assets | $756.20M | $763.61M | $764.99M | $774.33M | $773.93M | — | -1.0% |
| Total current liabilities | $221.04M | $224.87M | $219.02M | $30.75M | $30.15M | — | -1.7% |
| Current debt | $185.85M | $185.55M | $185.26M | — | — | $14.47M | +0.2% |
| Long-term debt | $985.00K | $1.03M | $1.09M | $186.09M | $185.83M | — | -4.1% |
| Total debt | $232.02M | $230.49M | $230.72M | $230.86M | $228.52M | — | +0.7% |
| Total liabilities | $265.50M | $268.62M | $262.35M | $261.06M | $258.54M | — | -1.2% |
| Retained earnings | -$707.68M | -$699.43M | -$688.88M | -$675.24M | -$668.24M | — | -1.2% |
| Shareholder equity | $490.70M | $494.99M | $502.64M | $513.27M | $515.39M | — | -0.9% |
| Working capital | $239.17M | $245.67M | $257.16M | $454.09M | $459.34M | — | -2.6% |
| Net tangible assets | $332.64M | $334.13M | $342.16M | $349.61M | $353.09M | — | -0.4% |
| Shares issued | 50.65M | 50.20M | 49.85M | 50.07M | 50.28M | — | +0.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$8.26M | -$10.54M | -$11.64M | -$6.94M | $108.87M | +21.7% |
| Depreciation & amortisation | $6.59M | $6.40M | $6.36M | $6.42M | $7.30M | +2.9% |
| Stock-based compensation | $2.40M | $2.40M | $2.43M | $2.53M | $2.38M | +0.3% |
| Change in working capital | -$851.00K | $1.69M | -$2.28M | -$1.32M | -$9.03M | -150.3% |
| Operating cash flow | $1.13M | $3.73M | $919.00K | $2.19M | -$7.34M | -69.7% |
| Capital expenditure | -$9.81M | -$10.28M | -$4.94M | -$4.28M | -$6.20M | +4.6% |
| Investing cash flow | -$5.81M | $18.72M | $56.00K | $14.31M | $230.04M | -131.1% |
| Share buybacks | — | — | -$2.01M | -$3.75M | — | — |
| Financing cash flow | $653.00K | $85.00K | -$2.15M | -$2.87M | -$15.86M | +668.2% |
| Free cash flow | -$8.68M | -$6.55M | -$4.03M | -$2.09M | -$13.55M | -32.6% |
| End cash position | $269.27M | $272.91M | $250.49M | $255.81M | $243.42M | -1.3% |
Options analytics
Put / call volume
0.04
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
12.50
-29.8% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
-21.9%
Calls bid over puts
Call volume
25
Contracts, this expiry
Put volume
1
Contracts, this expiry
Heaviest call OI
15.00
0 contracts
Heaviest put OI
12.50
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.18 | -0.20 | -9.1% |
| Mar 2026 | -0.19 | -0.19 | +1.8% |
| Dec 2025 | -0.21 | -0.17 | +17.6% |
| Sep 2025 | -0.19 | -0.13 | +31.7% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.17 | 3 | $48.69M | +10.1% |
| Next quarter | -0.17 | 3 | $50.04M | +10.1% |
| Current year | -0.77 | 3 | $195.48M | +11.0% |
| Next year | -0.66 | 3 | $214.98M | +10.0% |
Analyst targets & ownership
Mean target$19.67
High target$25.00
Low target$15.00
Implied upside10.49%
Analyst count9
ConsensusSTRONG BUY
Strong buy / Buy1 / 7
Hold1
Sell / Strong sell0 / 0
Held by insiders3.86%
Held by institutions95.25%
Institutions holding247
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
17.51
+1.64% from price
SMA 20
16.94
+5.06% from price
SMA 50
16.15
+10.22% from price
SMA 100
15.69
+13.45% from price
SMA 200
12.63
+40.96% from price
EMA 12
17.40
+2.28% from price
EMA 26
16.93
+5.16% from price
EMA 50
16.37
+8.74% from price
RSI (14)
64.9
Neutral
MACD (12,26,9)
0.48
Hist 0.05
ATR (14)
0.60
3.35% of price
Realised vol 30D
27.0%
Annualised
Bollinger upper
18.63
20, 2σ
Bollinger lower
15.25
20, 2σ
50 / 200 cross
Golden
16.15 vs 12.63
Trend bias
Above 200
+40.96%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.51
More volatile than market
Correlation to SPY
0.39
Loosely linked
Realised vol 30D
27.0%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-31.5%
Peak to trough
Max drawdown 5Y
-94.4%
Peak to trough
ATR 14
0.60
3.35% of price
Beta (reported)
1.96
5Y monthly, from filing
Short interest
Shares short
2.79M
Prior 2.52M
Change vs prior
+10.8%
Shorts adding
% of float
6.62%
Normal
% of shares out
5.50%
Against total outstanding
Days to cover
5.3
Crowded exit
Float
45.95M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 1, 26 | Guggenheim | MAINTAINED | Buy | Buy |
| Sep 18, 26 | BTIG | MAINTAINED | Buy | Buy |
| Aug 7, 26 | Guggenheim | MAINTAINED | Buy | Buy |
| Aug 7, 26 | Needham | MAINTAINED | Buy | Buy |
| Jul 24, 26 | BTIG | MAINTAINED | Buy | Buy |
| Jun 3, 26 | Craig-Hallum | MAINTAINED | Buy | Buy |
| May 20, 26 | Keybanc | MAINTAINED | Overweight | Overweight |
| May 5, 26 | Guggenheim | MAINTAINED | Buy | Buy |
| May 5, 26 | Needham | MAINTAINED | Buy | Buy |
| May 5, 26 | BTIG | MAINTAINED | Buy | Buy |
| Mar 30, 26 | Craig-Hallum | INITIATED | — | Buy |
| Mar 4, 26 | Needham | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split1:12
Split dateMay 19, 2015
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-08-06
Notice of termination of registration of a class of securities under Section 12(g)
15-12G · 2026-06-22
Corporate Changes & Voting Matters
8-K · 2026-06-09
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-05-29
Periodic Financial Reports
10-Q · 2026-05-05
Corporate Changes & Voting Matters
8-K · 2026-05-04
Proxy Statements
DEF 14A · 2026-04-22
Periodic Financial Reports
10-K · 2026-03-05
Headlines
Is CryoPort (CYRX) Outperforming Other Medical Stocks This Year?
Zacks · 5d ago
Cryoport (CYRX) Stock Fair Value Rises After Analysts Lift Growth Assumptions
Simply Wall St. · 44d ago
Cryoport (CYRX) Q2 2026 Earnings Call Transcript
Motley Fool · 54d ago
CryoPort (CYRX) Upgraded to Buy: Here's Why
Zacks · 57d ago
Investor Confidence in CryoPort (CYRX) Strengthened Backed by Pipeline Expansion
Insider Monkey · 61d ago
Cryoport, Inc. Q2 2026 Earnings Call Summary
Moby · 61d ago
CryoPort Inc (CYRX) (Q2 2026) Earnings Call Highlights: Positive EBITDA Milestone and 15% ...
GuruFocus.com · 61d ago
CryoPort Q2 Earnings Call Highlights
MarketBeat · 61d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.